The Latest Breaking News from AbbVie Inc

With slowing inflation, indications of slower rate hikes by the Fed beginning this month, and resilient employment growth, fundamentally strong stocks AbbVie (ABBV), Oracle Corporation (ORCL), and McKesson (MCK) could be opportune investments now. Continue reading….

While the stock market has been under pressure this year, medical stocks have remained resilient due to the inelastic demand for their offerings. Moreover, the demand for medical goods and services is rising amid increasing health awareness and chronic diseases. Given the solid prospects of the industry, fundamentally sound medical…

The stock market has experienced wild swings this year amid the Fed’s battle to curb the multi-decade high inflation levels with its stringent interest rate hikes. This has raised recession fears, and many economists now foresee an economic downturn. Amid the market turbulence, investors could buy dividend aristocrats AbbVie (ABBV),…

While the impact of further rate hikes has been majorly factored into the stock market, it could be wise to invest in fundamentally sound stocks AbbVie (ABBV), AT&T (T), and Molina Healthcare (MOH) to tide over any possible the turbulences. Continue reading….

The Fed Chairman recently indicated a slower pace of rate increases. However, many analysts still believe the economy will face a mild recession next year. Therefore, it could be wise to invest in quality stocks with solid growth prospects, such as AbbVie (ABBV), Bristol-Myers Squibb (BMY), and Lifeway Foods (LWAY).…

Although the stock market remains highly volatile due to high inflation levels and the Fed’s aggressive monetary policy stance, analysts believe consumer prices will significantly decline in 2023. Moreover, the Fed also signaled slower rate hikes ahead. So, fundamentally strong stocks, AbbVie (ABBV), CSX Corporation (CSX), Waste Management (WM), Stellantis…

The healthcare industry is expected to witness significant growth in the foreseeable future, driven by rising health awareness, an aging population, and increasing chronic diseases worldwide. Furthermore, the healthcare industry is known to perform steadily regardless of economic conditions because of the inelastic demand for healthcare products and services. Therefore,…

The global healthcare industry is showing robust growth prospects with the growing adoption of advanced technologies, rising health awareness, and increasing chronic diseases. Amid rising spending on medicines, fundamentally strong healthcare stocks AbbVie (ABBV) and Bristol-Myers Squibb (BMY) might be ideal additions to your portfolio now. Read on.

Biopharma giant AbbVie (ABBV) is well-placed to gain from its drug pipeline, recent drug approvals, and strategic acquisitions. Given its strong fundamentals, discounted valuation, high profitability, reliable dividends, and favorable analyst estimates, investing in this stock could help you retire earlier. Read more.

Leading biopharmaceutical company AbbVie Inc. (ABBV) is well-positioned to benefit from its diversified portfolio, research breakthroughs, drug and therapy approvals, acquisitions, and partnerships. The company has been increasingly paying dividends, supported by its stable earnings stream. Therefore, investors looking for passive income amid uncertain market conditions could invest in this…

Amid sky-high inflation and consecutive big rate hikes, recessionary fears are looming. We believe fundamentally sound and stable dividend-paying stocks Walmart (WMT), AbbVie (ABBV), Coca-Cola Company (KO), and International Paper Company (IP) could be ideal investments to navigate a bear market. Read more.